Combination therapy in the patient with glaucoma and endothelial corneal dystrophy treatment: clinical case



Cite item

Full Text

Abstract

Background. Penetrating keratoplasty improves visual acuity in patients with various corneal conditions. However, like any form of surgery it can lead to complications and there are number of contraindications. Uncompensated glaucoma is one of the poor prognostic factors for penetrating keratoplasty. Penetrating keratoplasty can result in postoperative reactive hypertension, although it is not a common condition. This complication is associated with glaucoma patients whereas patients who has not been previously diagnosed with glaucoma suffer from postoperative reactive hypertension much less. Increased intraocular pressure in glaucoma patients can lead to disease progression and graft failure. Clinical case description. This clinical case presents a juvenile glaucoma patient, who underwent surgery for glaucoma several times and after that underwent the EX-PRESS glaucoma filtration device implantation. The EX-PRESS device contacted with the posterior surface of the cornea that resulted in endothelial corneal dystrophy development with corneal opacities and pain. The EX-PRESS device was removed and penetrating keratoplasty was performed, since critical flicker frequency was high (30 Hz), so that a sufficiently good visual outcome was expected. However, despite the maximum medical therapy in glaucoma, intraocular pressure remained high, so transscleral diode laser cyclophotocoagulation had been applied. Conclusion. The clinical case demonstrates the effectiveness of transscleral diode laser cyclophotocoagulation in the patient with repeatedly operated refractory glaucoma before penetrating keratoplasty.

Key words: clinical case, transscleral diode laser cyclophotocoagulation, refractory glaucoma, juvenile glaucoma, intraocular pressure, penetrating keratoplasty.

 

For citation:

Arzhimatova GSh, Alekseev IB, Ibraimov AI, Popova LA. Combination therapy in the patient with glaucoma and endothelial corneal dystrophy treatment: clinical case.
Journal of Clinical Practice
. 2024;00(0):0–00. doi:

Full Text

ADDITIONAL INFORMATION

Funding source. The authors declare that there was no external funding for the study.

Competing interests. The authors declare that they have no competing interests.

Authors’ contribution. L.A. Popova — study design development, review of publications on the topic of the article, manuscript writing; A.I. Ibraimov — patient treatment, approval of the concept and design of the study, manuscript writing; I.B. Alekseev — patient treatment, approval of the concept and design of the study, editing; G.Sh. Arzhimatova — manuscript editing.

All authors made a substantial contribution to the conception of the work, acquisition, analysis, interpretation of data for the work, drafting and revising the work, final approval of the version to be published and agree to be accountable for all aspects of the work.

Consent for publication. Voluntary written informed consent was not obtained from the patient because the study does not contain any personally identifying information.

×

About the authors

Gulzhiyan Sh Arzhimatova

Botkin Hospital, Moscow, Russian Federation; Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation

Email: okb7@mail.ru

Кандидат медицинских наук, руководитель МГОЦ ММНКЦ им. С.П. Боткина, доцент кафедры офтальмологии РМАНПО.
Russian Federation

Igor B Alekseev

Botkin Hospital, Moscow, Russian Federation; Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation

Email: ialekseev63@mail.ru

Доктор медицинских наук, профессор кафедры офтальмологии РМАНПО, врач-офтальмолог офтальмологического отделения №64 МГОЦ ММНКЦ им. С.П. Боткина
Russian Federation

Alim I Ibraimov

Botkin Hospital, Moscow, Russian Federation

Email: lexus.simf@gmail.com

Врач-офтальмолог офтальмологического отделения №60 МГОЦ ММНКЦ им. С.П. Боткина
Russian Federation

Liliya A Popova

Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: lilotek42@yandex.ru

Ординатор 2 года кафедры офтальмологии РМАНПО
Russian Federation

References

  1. Кански Д. Кератопластика. В кн.: Клиническая офтальмология: систематизированный подход; 2-е изд. Под ред. Еричева В.П.: Издательство «Elsevier Urban & Partner»; 2009: 313–317. [Kanski J Keratoplastika. In.: Yerichev VP (ed.) Klinicheskaya oftal'mologiya: sistematizirovannyy podkhod; 2-ye izd. M.: Izdatel'stvo «Elsevier Urban & Partner»; 2009: 313–317. (In Russ.)]
  2. Маложен С.А. Совершенствование системы реконструктивных операций у больных с осложненными бельмами и рефрактерной глаукомой. Автореферат диссертации на соискание ученой степени доктора медицинских наук. М.; 2009. [Malozhen SA. Sovershenstvovaniye sistemy rekonstruktivnykh operatsiy u bol'nykh s oslozhnennymi bel'mami i refrakternoy glaukomoy. [Dissertation]. M.; 2009. (In Russ.)]
  3. Труфанов С.В., Маложен С.А., Сипливый В.И., Пивин Е.А. Оценка влияния сопутствующей глаукомы на результаты эндотелиальной кератопластики при буллезной кератопатии. Национальный журнал Глаукома. 2015;14(1):62-67. [Trufanov S.V., Malozhen S.A., Siplivy V.I., Pivin E.A. Evaluation of the influence of concomitant glaucoma for endothelial keratoplasty outcomes in bullous keratopathy treatment. National Journal glaucoma. 2015;14(1):62-67. (In Russ.)]
  4. Chien AM, Schmidt CM, Cohen EJ, Rajpal RK, Sperber LT, Rapuano CJ, Moster M, Smith M, Laibson PR. Glaucoma in the immediate postoperative period after penetrating keratoplasty. Am J Ophthalmol. 1993 Jun 15;115(6):711-4. doi: 10.1016/s0002-9394(14)73636-0
  5. Sihota R, Sharma N, Panda A, Aggarwal HC, Singh R. Post-penetrating keratoplasty glaucoma: risk factors, management and visual outcome. Aust N Z J Ophthalmol. 1998 Nov;26(4):305-9. doi: 10.1111/j.1442-9071.1998.tb01334.x
  6. Клинические рекомендации. Глаукома первичная открытоугольная. М.: 2022. [Klinicheskiye rekomendatsii. Glaukoma pervichnaya otkrytougol'naya. M.: 2022. (In Russ.)]
  7. Kornmann HL, Gedde SJ. Glaucoma management after corneal transplantation surgeries. Curr Opin Ophthalmol. 2016 Mar;27(2):132-9. doi: 10.1097/ICU.0000000000000237
  8. Dumitrescu OM, Istrate S, Macovei ML, Gheorghe AG. Intraocular Pressure Measurement after Penetrating Keratoplasty. Diagnostics (Basel). 2022 Jan 19;12(2):234. doi: 10.3390/diagnostics12020234
  9. Патогенез и лечение ожогов глаз и их последствий. Под ред. Пучковской Н.А., Шульгиной Н.С., Непомящей В.М. М.: Издательство «Медицина»; 1973. [Puchkovskaya NA, Shulgina NS, Nepomnyashchaya VM (eds). Patogenez i lecheniye ozhogov glaz i ikh posledstviy. M.: Izdatel'stvo «Meditsina»; 1973. (In Russ.)]
  10. Клинические рекомендации. Ожоги глаз. М.: 2023. [Klinicheskiye rekomendatsii. Ozhogi glaz. M.: 2023. (In Russ.)]

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 38032 от 11 ноября 2009 года.